| Monovalent, reduced-size quantum dots for imaging receptors on living cells M Howarth, W Liu, S Puthenveetil, Y Zheng, LF Marshall, MM Schmidt, ... Nature methods 5 (5), 397-399, 2008 | 523 | 2008 |
| A fluorophore ligase for site-specific protein labeling inside living cells C Uttamapinant, KA White, H Baruah, S Thompson, M Fernández-Suárez, ... Proceedings of the National Academy of Sciences 107 (24), 10914-10919, 2010 | 347 | 2010 |
| Yeast display evolution of a kinetically efficient 13-amino acid substrate for lipoic acid ligase S Puthenveetil, DS Liu, KA White, S Thompson, AY Ting Journal of the American Chemical Society 131 (45), 16430-16438, 2009 | 119 | 2009 |
| An Engineered Aryl Azide Ligase for Site-Specific Mapping of Protein-Protein Interactions via Photocrosslinking H Baruah, S Puthenveetil, YA Choi, S Shah, AY Ting Angewandte Chemie (International ed. in English) 47 (37), 7018, 2008 | 111 | 2008 |
| Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modification S Puthenveetil, L Whitby, J Ren, K Kelnar, JF Krebs, PA Beal Nucleic acids research 34 (17), 4900-4911, 2006 | 96 | 2006 |
| Optimization of tubulysin antibody–drug conjugates: a case study in addressing ADC metabolism LN Tumey, CA Leverett, B Vetelino, F Li, B Rago, X Han, F Loganzo, ... ACS Medicinal Chemistry Letters 7 (11), 977-982, 2016 | 79 | 2016 |
| Development of solid-phase site-specific conjugation and its application toward generation of dual labeled antibody and fab drug conjugates S Puthenveetil, S Musto, F Loganzo, LN Tumey, CJ O’Donnell, E Graziani Bioconjugate chemistry 27 (4), 1030-1039, 2016 | 72 | 2016 |
| Site selection: a case study in the identification of optimal cysteine engineered antibody drug conjugates LN Tumey, F Li, B Rago, X Han, F Loganzo, S Musto, EI Graziani, ... The AAPS journal 19, 1123-1135, 2017 | 68 | 2017 |
| Natural product splicing inhibitors: a new class of antibody–drug conjugate (ADC) payloads S Puthenveetil, F Loganzo, H He, K Dirico, M Green, J Teske, S Musto, ... Bioconjugate chemistry 27 (8), 1880-1888, 2016 | 62 | 2016 |
| PF-06804103, a site-specific anti-HER2 antibody–drug conjugate for the treatment of HER2-expressing breast, gastric, and lung cancers EI Graziani, M Sung, D Ma, B Narayanan, K Marquette, S Puthenveetil, ... Molecular cancer therapeutics 19 (10), 2068-2078, 2020 | 38 | 2020 |
| Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate S Puthenveetil, H He, F Loganzo, S Musto, J Teske, M Green, X Tan, ... PloS one 12 (5), e0178452, 2017 | 36 | 2017 |
| Determination of antibody–drug conjugate released payload species using directed in vitro assays and mass spectrometric interrogation AJ Bessire, TE Ballard, M Charati, J Cohen, M Green, MH Lam, ... Bioconjugate chemistry 27 (7), 1645-1654, 2016 | 30 | 2016 |
| Design and development of glucocorticoid receptor modulators as immunology antibody–drug conjugate payloads AD Hobson, MJ McPherson, W Waegell, CA Goess, RH Stoffel, X Li, ... Journal of Medicinal Chemistry 65 (6), 4500-4533, 2022 | 23 | 2022 |
| Spliceostatin analogs and methods for their preparation C Subramanyam, FE Koehn, KJ Dirico, AS Eustaquio, ME Green, H He, ... US Patent 9,169,264, 2015 | 14 | 2015 |
| Site‐Specific Modification of Epstein–Barr Virus‐Encoded RNA 1 with N2‐Benzylguanosine Limits the Binding Sites Occupied by PKR S Puthenveetil, EA Véliz, PA Beal ChemBioChem 5 (3), 383-386, 2004 | 12 | 2004 |
| Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model P Gupta, ZK Jiang, B Yang, L Manzuk, E Rosfjord, J Yao, L Lemon, ... MAbs 13 (1), 1958662, 2021 | 7 | 2021 |
| O, Donnell, CJ; Subramanyam, C LN Tumey, CA Leverett, B Vetelino, F Li, B Rago, X Han, F Loganzo, ... ACS Med. Chem. Lett 7, 977-982, 2016 | 5 | 2016 |
| Spliceostatin analogs and methods for their preparation C Subramanyam, FE Koehn, KJ Dirico, AS Eustaquio, ME Green, H He, ... US Patent 9,504,669, 2016 | 4 | 2016 |
| Detection and removal of small molecule and endotoxin contaminants in ADC preparations J Casavant, AS Ratnayake, S Puthenveetil, LN Tumey Antibody-Drug Conjugates: Methods and Protocols, 291-299, 2020 | 2 | 2020 |
| Spliceostatin analogs KJ DIRICO, AS EUSTAQUIO, ME GREEN, H He, M He, FE KOEHN, ... | 2 | 2018 |
